GPT and metabolic disease: The primary mechanism suggested is that an elevated AST/ALT ratio may indicate liver damage, leading to the accumulation of toxic metabolites, which is associated with systemic inflammatory responses and metabolic diseases—all of which are factors related to colorectal cancer.